- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
NAD+ Coenzyme IV Therapy · Educational Resource
Understanding NAD+ IV Infusion and Cellular Restoration Research
Therapy Classification
Direct intravenous NAD+ coenzyme replenishment
Key Research Areas
Cellular energy metabolism, cognitive function, and recovery support research
Administration Protocol
Intravenous infusion, administered in a clinical setting
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →NAD+ Coenzyme IV Therapy · Educational Resource
Understanding NAD+ IV Infusion and Cellular Restoration Research
01 — Overview
What is NAD+ IV Infusion?
NAD+ IV Infusion delivers nicotinamide adenine dinucleotide (NAD+) directly into the bloodstream, an approach studied as a way to bypass the digestive breakdown and absorption limitations that oral NAD+ precursors like NMN or NR must overcome before reaching circulation.
To understand its role, it helps to think of oral NAD+ precursors as raw materials shipped through a long supply chain—digestion, absorption, liver processing—before reaching your cells, whereas IV infusion is more like delivering the finished coenzyme directly to the warehouse door, administered under direct clinical supervision.
NAD+ IV infusion protocols are administered exclusively in a clinical setting under the supervision of a licensed healthcare provider. This form of NAD+ delivery is studied in observational and pilot clinical research rather than as an FDA-approved standardized drug protocol, and it should only be administered following a medical consultation.
02 — How it works
How It Works: Bypassing Absorption Barriers
The primary interest researchers evaluate with intravenous NAD+ delivery is whether direct bloodstream administration achieves higher and more immediate circulating NAD+ availability compared to oral precursor supplementation, given that oral forms are subject to first-pass liver metabolism.
Because NAD+ is a coenzyme required by hundreds of cellular reactions, including those governing mitochondrial ATP production and DNA repair enzymes, studies also evaluate infusion protocols' potential associations with reported energy, cognitive clarity, and recovery-support outcomes.
Administration Guidance
NAD+ IV Infusion is administered exclusively in a clinical setting by trained medical staff, typically over the course of one to several hours depending on the protocol and dose. Pre-infusion screening and monitoring throughout the session are standard practice given the systemic nature of intravenous administration.
03 — Areas of research
Summary of Investigated Research Areas
Ongoing observational and pilot clinical research continues to evaluate NAD+ IV infusion across several relevant areas, particularly relating to cellular energy metabolism, cognitive function, and recovery support protocols.
Bypassing Oral Absorption Limits
Pilot studies evaluate plasma NAD+ metabolite levels following IV infusion compared to oral precursor administration.
Cellular Energy & Fatigue Research
Observational research explores reported changes in subjective energy levels following NAD+ infusion protocols.
Cognitive Clarity Research
Studies investigate NAD+'s coenzyme role in neuronal energy metabolism and its association with cognitive function reports.
Recovery Support Protocols
Clinical literature examines NAD+ infusion's historical use as a supportive protocol in recovery and rehabilitation settings.
DNA Repair Enzyme Cofactor Research
Research evaluates NAD+'s role as an essential cofactor for PARP and sirtuin enzymes involved in DNA repair.
Pharmacokinetic Infusion Studies
Studies assess infusion rate, duration, and plasma clearance patterns to inform IV NAD+ protocol design.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
Grant, R., Berg, J., Mestayer, R., et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+.. Frontiers in Aging Neuroscience, 11, 257.
Braidy, N., Berg, J., Clement, J., et al. (2019). Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.. Antioxidants & Redox Signaling, 30(2), 251-294.
Braidy, N., & Liu, Y. (2020). NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.. Experimental Gerontology, 132, 110831.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
